Sign up to save your podcasts
Or
Share Rondell Graham, M.B.B.S., Head of GI and Liver Pathology at the Mayo Clinic, Predictive and Prognostic Factors in Colon Cancer - episode 15
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Rondell Graham, M.B.B.S., Head of GI and Liver Pathology at the Mayo Clinic, Predictive and Prognostic Factors in Colon Cancer - episode 15
2020 marks the one hundredth anniversary of the publication of Albert Broder’s landmark paper on tumor grading.
The foundation of what is now called personalized medicine is the idea that not all tumors or all patients are the same. Differences in gene expression and phenotype correlate with outcome and inform how a patient is best treated.
Dr. Rondell Graham is head of gastrointestinal and liver pathology at the Mayo Clinic. He joins us to discuss predictive and prognostic markers in colon cancer - where we've been, the implications of new technologies such as artificial intelligence, as well as the future of targeted therapies.
View all episodes
By Joseph Anderson, MD
4.5
22 ratings
2020 marks the one hundredth anniversary of the publication of Albert Broder’s landmark paper on tumor grading.
The foundation of what is now called personalized medicine is the idea that not all tumors or all patients are the same. Differences in gene expression and phenotype correlate with outcome and inform how a patient is best treated.
Dr. Rondell Graham is head of gastrointestinal and liver pathology at the Mayo Clinic. He joins us to discuss predictive and prognostic markers in colon cancer - where we've been, the implications of new technologies such as artificial intelligence, as well as the future of targeted therapies.